Illumina to cut $100M in costs to cope with China ban
The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.
Fierce Biotech2d
Illumina aims to cut $100M in costs following China import ban
Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...
Trade War Fallout Prompts San Diego’s Illumina to Lower Outlook, Cut $100 Million in Costs
Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban on imports of its genetic sequencing instruments.
TMCnet3d
Illumina addresses recent developments in China
"Our new fiscal 2025 guidance provides for limited further earnings contribution from China, and assumes a continuation of the macro trends we see today," said Ankur Dhingra, CFO of Illumina. "We will ...
Illumina lowers outlook due to China sales ban, to cut $100 million in costs
Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban ...
MedTech Dive7d
Illumina’s DNA sequencers hit with China import ban
Illumina is not banned from operating in the country and will continue to serve its existing customers, a company ...
Illumina named to Dow Jones Best-in-Class Indices for sixth consecutive year and as a Sustainability Yearbook Member for fourth consecutive year
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, has been named for the sixth ...
Nature8d
DNA articles from across Nature Portfolio
DNA (deoxyribonucleic acid) is the nucleic acid polymer that forms the genetic code for a cell or virus. Most DNA molecules consist of two polymers (double-stranded) of four nucleotides that each ...
China hits Illumina with import ban. What does that mean for the San Diego gene sequencer?
China imposed an import ban on Illumina’s gene sequencers in response to President Trump’s escalating tariffs and trade war ...
China bans Illumina sequencer imports as US trade war intensifies
GlobalData’s senior medical analyst says the ban will add to a downward trend for Illumina in the Chinese market.
Illumina: Navigating Headwinds As China Bans Instruments And Roche Enters The NGS Race
Illumina navigates competition and geopolitical risks with improved margins and strong cash flow. Read my analysis of ILMN ...
PharmiWeb9d
Global DNA Diagnostics Market Set to Surge, Reaching USD 57,420.1 Million by 2034 at a CAGR of 7.8% | FMI
The global DNA diagnostics market is on an impressive growth trajectory, with sales projected to reach USD 27,094.2 million in 2024, and further expanding to USD 57,420.1 million by 2034. This surge ...